6,142 results match your criteria Osteoporosis Secondary

Risk factors for a second nonsimultaneous hip fracture in a prospective cohort study.

Arch Orthop Trauma Surg 2021 Jun 14. Epub 2021 Jun 14.

Musculoskeletal Research Unit, IMIM-Parc Salut Mar, CIBERFES, Universitat Autonoma de Barcelona, Doctor Aiguader 88, 20, 08003, Barcelona, Spain.

Introduction: The risk factors for a second nonsimultaneous hip fracture are unclear, and in general, it is empirically assumed that they are similar to those associated with the first hip fracture. We aimed to determine the incidence of a second hip fracture and define the characteristics of the patients sustaining the event in a prospective cohort study in a Spanish population.

Materials And Methods: We conducted a multicentric, prospective cohort study in a representative sample of 45 hospitals from 15 autonomic regions in Spain. Read More

View Article and Full-Text PDF

WNT7B overexpression rescues bone loss caused by glucocorticoids in mice.

FASEB J 2021 Jul;35(7):e21683

Department of Orthopedic Surgery, Washington University School of Medicine, St. Louis, MO, USA.

Glucocorticoids, widely prescribed for anti-inflammatory and immunosuppressive purposes, are the most common secondary cause for osteoporosis and related fractures. Current anti-resorptive and anabolic therapies are insufficient for treating glucocorticoid-induced osteoporosis due to contraindications or concerns of side effects. Glucocorticoids have been shown to disrupt Wnt signaling in osteoblast-lineage cells, but the efficacy for Wnt proteins to restore bone mass after glucocorticoid therapy has not been examined. Read More

View Article and Full-Text PDF

An emerging role of Prevotella histicola on estrogen deficiency-induced bone loss through the gut microbiota-bone axis in postmenopausal women and in ovariectomized mice.

Am J Clin Nutr 2021 Jun 10. Epub 2021 Jun 10.

Department of Orthopaedics, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Background: The gut microbiota (GM)-bone axis has emerged as a crucial mediator of bone homeostasis. Estrogen deficiency-induced bone loss is closely associated with an altered GM. However, the underlying mechanisms remain unclear. Read More

View Article and Full-Text PDF

Short-term glucocorticoid excess blunts abaloparatide-induced increase in femoral bone mass and strength in mice.

Sci Rep 2021 Jun 10;11(1):12258. Epub 2021 Jun 10.

Department of Biomedicine, Health, Aarhus University, Wilhelm Meyers Allé 3, 8000, Aarhus C, Denmark.

Glucocorticoids (GCs), such as prednisolone, are widely used to treat inflammatory diseases. Continuously long-term or high dose treatment with GCs is one of the most common causes of secondary osteoporosis and is associated with sarcopenia and increased risk of debilitating osteoporotic fragility fractures. Abaloparatide (ABL) is a potent parathyroid hormone-related peptide analog, which can increase bone mineral density (aBMD), improve trabecular microarchitecture, and increase bone strength. Read More

View Article and Full-Text PDF

Raloxifene retards the progression of adjacent segmental intervertebral disc degeneration by inhibiting apoptosis of nucleus pulposus in ovariectomized rats.

J Orthop Surg Res 2021 Jun 9;16(1):368. Epub 2021 Jun 9.

Department of Orthopedic Surgery, Hebei Medical University, 361 Zhongshan E Rd, Shijiazhuang, Hebei, 050000, People's Republic of China.

Background: Adjacent segmental intervertebral disk degeneration (ASDD) is a major complication secondary to lumbar fusion. Although ASSD pathogenesis remains unclear, the primary cause of intervertebral disk degeneration (IVDD) development is apoptosis of nucleus pulposus (NP). Raloxifene (RAL) could delay ASDD by inhibiting NP apoptosis. Read More

View Article and Full-Text PDF

Anorexia nervosa: COVID-19 pandemic period (Review).

Exp Ther Med 2021 Aug 26;22(2):804. Epub 2021 May 26.

Department of Endocrinology, Clinical County Hospital, 400000 Cluj-Napoca, Romania.

Anorexia nervosa is an eating disorder characterized by restrictive eating and an intense fear of gaining weight. It is a disease with an increasing incidence during the last few decades, and represents a complex psychiatric condition which includes secondary amenorrhea, nutritional and metabolic damage, and impaired endocrine panel up to bone loss as well as cardiac, gastrointestinal and hematological complications. This is a narrative review which includes an update on this eating disorder from the perspective of an endocrine panel of anomalies, especially of the skeleton, considering the pressure of the recent global COVID-19 pandemic changes. Read More

View Article and Full-Text PDF

Denosumab versus romosozumab for postmenopausal osteoporosis treatment.

Sci Rep 2021 Jun 3;11(1):11801. Epub 2021 Jun 3.

Department of Orthopaedic Surgery, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan.

Denosumab and romosozumab, a recently approved new drug, are effective and widely known molecular-targeted drugs for postmenopausal osteoporosis treatment. However, no studies have directly compared their therapeutic effects or safety in postmenopausal osteoporosis. This retrospective observational registry study compared the efficacy of 12-month denosumab or romosozumab treatment in postmenopausal osteoporosis patients. Read More

View Article and Full-Text PDF

SCOPE 2021: a new scorecard for osteoporosis in Europe.

Arch Osteoporos 2021 Jun 2;16(1):82. Epub 2021 Jun 2.

Quantify Research, Stockholm, Sweden.

This scorecard summarises key indicators of the burden of osteoporosis and its management in the 27 member states of the European Union, as well as the UK and Switzerland. The resulting scorecard elements, assembled on a single sheet, provide a unique overview of osteoporosis in Europe.

Introduction: The scorecard for osteoporosis in Europe (SCOPE) is a project of the International Osteoporosis Foundation (IOF) that seeks to raise awareness of osteoporosis care in Europe. Read More

View Article and Full-Text PDF

The Risk of Osteoporosis and Osteoporotic Fracture Following the Use of Irritable Bowel Syndrome Medical Treatment: An Analysis Using the OMOP CDM Database.

J Clin Med 2021 May 10;10(9). Epub 2021 May 10.

Pusan National University School of Medicine, Yangsan 50612, Korea.

Patients with irritable bowel syndrome (IBS) are at increased risk of osteoporosis and osteoporotic fracture. This study investigated whether IBS medication attenuated the rate of osteoporosis and osteoporotic fracture risk. We conducted a retrospective large-scale multicenter study across eight hospital databases encoded in the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM). Read More

View Article and Full-Text PDF

Association Between Parental Type 1 and Type 2 Diabetes Diagnosis and Major Osteoporotic Fracture Risk in Adult Offspring: A Population-Based Cohort Study.

Can J Diabetes 2021 Apr 21. Epub 2021 Apr 21.

Department of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

Objectives: Previous research suggests an intergenerational influence of diabetes on bone health. We examined the association between parental diabetes and major osteoporotic fracture (MOF) risk in offspring.

Methods: This population-based cohort study used de-identified administrative health data from Manitoba, Canada, which capture population-level records of hospitalizations, physician visits and drug dispensations. Read More

View Article and Full-Text PDF

Effect of high-intensity training on bone health and body composition in lung transplant recipients: A secondary analysis of a randomized controlled trial.

Clin Transplant 2021 May 28:e14375. Epub 2021 May 28.

Norwegian School of Sport Sciences, Institute of Physical Performance, Oslo, Norway.

Background: Loss of bone mineral and skeletal muscle mass is common after lung transplantation (LTx), and physical activity (PA) may prevent further deterioration. We aimed to assess the effects of 20-week high-intensity training (HIT) on body composition, bone health, and PA in LTx recipients, 6-60 months after surgery.

Methods: In a randomized controlled trial, 51 LTx recipients underwent Dual-energy X-ray absorptiometry (DXA), and PA level and sedentary time were objectively recorded by accelerometers for seven consecutive days. Read More

View Article and Full-Text PDF

Premenopausal osteoporosis.

Climacteric 2021 May 26:1-14. Epub 2021 May 26.

Medi-Clinic, Cape Town, South Africa.

In premenopausal women, bone mineral density measurement by dual-energy X-ray absorptiometry should not be used as the sole guide for diagnosis or treatment of osteoporosis, universal screening with bone mineral density is not advised and the World Health Organization classification of bone status should not be applied. A diagnosis of premenopausal osteoporosis is reserved for those with evidence of fragility and may also be considered in women with low bone mass and an ongoing secondary cause of osteoporosis. Idiopathic osteoporosis in young women is rare. Read More

View Article and Full-Text PDF

Disturbance of osteonal bone remodeling and high tensile stresses on the lateral cortex in atypical femoral fracture after long-term treatment with Risedronate and Alfacalcidol for osteoporosis.

Bone Rep 2021 Jun 7;14:101091. Epub 2021 May 7.

Niigata Rehabilitation Hospital, 761 Kizaki, Kita-ku, Niigata-shi, Niigata 950-3304, Japan.

An 83 year-old Japanese woman complained of left lateral thigh pain following a low-energy fall 4 months prior to admission. She had been treated for osteoporosis with Risedronate and Alfacalcidol for the previous five years. She was diagnosed with an atypical femoral fracture (AFF) according to the American Society for Bone and Mineral Research (ASBMR) Task Force revised criteria. Read More

View Article and Full-Text PDF

The clinical application of high-resolution peripheral computed tomography (HR-pQCT) in adults: state of the art and future directions.

Osteoporos Int 2021 May 22. Epub 2021 May 22.

INSERM UMR 1033, Université de Lyon, Hôpital E Herriot, 69437 cedex 03, Lyon, France.

High-resolution peripheral computed tomography (HR-pQCT) was developed to image bone microarchitecture in vivo at peripheral skeletal sites. Since the introduction of HR-pQCT in 2005, clinical research to gain insight into pathophysiology of skeletal fragility and to improve prediction of fractures has grown. Meanwhile, the second-generation HR-pQCT device has been introduced, allowing novel applications such as hand joint imaging, assessment of subchondral bone and cartilage thickness in the knee, and distal radius fracture healing. Read More

View Article and Full-Text PDF

Glucocorticoid- and Transplantation-Induced Osteoporosis.

Endocrinol Metab Clin North Am 2021 Jun;50(2):251-273

Mayo Clinic E18-A, 200 1st Street Southwest, Rochester, MN 55905, USA. Electronic address:

Glucocorticoid-induced osteoporosis is the most common cause of secondary osteoporosis; nonetheless, it remains an undertreated condition. Transplantation-induced osteoporosis encompasses a broad range of unique pathogenetic features with distinct characteristics dependent on the transplanted organ. Understanding the pathogenesis of bone loss is key to recommending osteoporosis therapy in these patients. Read More

View Article and Full-Text PDF

Role of Bone Turnover Markers in Osteoporosis Therapy.

Sumeet Jain

Endocrinol Metab Clin North Am 2021 Jun 28;50(2):223-237. Epub 2021 Apr 28.

Division of Endocrinology and Metabolism, Department of Medicine, Rush University Medical Center, 1725 West Harrison Street, Suite 250, Chicago, IL 60612, USA. Electronic address:

Bone turnover markers fill a clinical need that improves comprehensive care of metabolic bone health and osteoporosis. Creating a standard process for drawing them that reduces modifiable variability improves their precision and clinical usefulness. Creating a standard process for interpreting them by applying statistical significance improves their clinical applicability. Read More

View Article and Full-Text PDF

Fenestrated pedicle screws for thoracolumbar instrumentation in patients with poor bone quality: Case series and systematic review of the literature.

Clin Neurol Neurosurg 2021 Jul 11;206:106675. Epub 2021 May 11.

Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA; Department of Neurosurgery, Zucker School of Medicine at Hofstra, Long Island Jewish Medical Center and North Shore University Hospital, Northwell Health, Manhasset, NY 11030, USA. Electronic address:

Objective: To describe the results of a single-surgeon series and systematically review the literature on cement-augmented instrumented fusion with fenestrated pedicle screws.

Methods: All patients treated by the senior surgeon using fenestrated screws between 2017 and 2019 with a minimum of 6-months of clinical and radiographic follow-up were included. For the systematic review, we used PRISMA guidelines to identify all prior descriptions of cement-augmented instrumented fusion with fenestrated pedicle screws in the English literature. Read More

View Article and Full-Text PDF

Prevalence of vertebral fractures and serum sclerostin levels in acromegaly.

Endocrine 2021 May 21. Epub 2021 May 21.

Division of Endocrinology and Metabolism, Marmara University School of Medicine, Istanbul, Turkey.

Objective: An increased prevalence of vertebral fractures (VFs) has been reported in previous studies. The aim of this study was to evaluate the association between bone mineral density (BMD), bone turnover markers, serum sclerostin levels, and vertebral fractures (VFs) in acromegaly patients. We also evaluated the effects of gonadal status, disease activity, treatment modality, age, sex, and body mass index (BMI) on skeletal endpoints. Read More

View Article and Full-Text PDF

Rheumatoid arthritis and osteoporosis: a bi-directional Mendelian randomization study.

Aging (Albany NY) 2021 05 18;13(10):14109-14130. Epub 2021 May 18.

Department of Orthopedics, The Second Xiangya Hospital of Central South University, Changsha 410011, China.

Many observation studies have demonstrated a close relationship between rheumatoid arthritis (RA) and osteoporosis (OP). However, the causal genetic correlation between RA and OP remains unclear. In this study, we performed bi-directional Mendelian randomization (MR) analyses to explore causal inference between these two traits. Read More

View Article and Full-Text PDF

Multidisciplinary care model for geriatric patients with hip fracture in Japan: 5-year experience.

Arch Orthop Trauma Surg 2021 May 20. Epub 2021 May 20.

Department of Geriatric Medicine, Kanazawa Medical University Himi Municipal Hospital, Toyama, Japan.

Introduction: Japan is a super-aging society, the geriatric care system establishment for hip fractures is at an urgent task. This report described our concept of multidisciplinary care model for geriatric hip fractures and 5-year outcomes at the Toyama City Hospital, Japan.

Methods: In this retrospective cohort study, a multidisciplinary treatment approach was applied for elderly patients with hip fracture since 2014. Read More

View Article and Full-Text PDF

[Cystic fibrosis being a polyendocrine disease (Review)].

Probl Endokrinol (Mosk) 2021 Mar 30;67(2):28-39. Epub 2021 Mar 30.

Stavropol Regional Clinical Consultative and Diagnostic Center.

The cystic fibrosis transmembrane regulator (CFTR) gene encodes the synthesis of a protein of the same name, which functions as a direct activator of anionic transport. Chloride is the most abundant anion; as an antagonist of Na+ and K+, it provides electroneutrality of cell membranes at rest; together with cations, it serves as an important osmolyte and forms water flow across cell membranes for transepithelial secretion.Glandular cells in CF trap Cl- and Na+, and the prodused secretion is excessively viscous. Read More

View Article and Full-Text PDF

The role of Serpina3n in the reversal effect of ATRA on dexamethasone-inhibited osteogenic differentiation in mesenchymal stem cells.

Stem Cell Res Ther 2021 May 17;12(1):291. Epub 2021 May 17.

Department of Orthopaedics, The Second Affiliated Hospital of Chongqing Medical University, 76 Linjiang Road, Yuzhong District, Chongqing, 400010, China.

Background: Glucocorticoid-induced osteoporosis (GIOP) is the most common secondary osteoporosis. Patients with GIOP are susceptible to fractures and the subsequent delayed bone union or nonunion. Thus, effective drugs and targets need to be explored. Read More

View Article and Full-Text PDF

Osteoporotic vertebral fractures: A diagnostic challenge in the 21 century.

Rev Clin Esp (Barc) 2021 Feb 3;221(2):118-124. Epub 2020 Apr 3.

Servicio de Medicina Interna, Unidad de Geriatria, Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.

Vertebral fractures are the most prevalent osteoporotic fractures and are paradoxically the most underdiagnosed. While only one-third of patients have acute pain, they can present other associated chronic complications. Vertrebal fractures are associated with the onset of new fractures, both vertebral and nonvertebral. Read More

View Article and Full-Text PDF
February 2021

Profile of patients who consult with internists for an osteoporosis assessment: The OSTEOMED registry.

Rev Clin Esp (Barc) 2021 Jan 7;221(1):9-17. Epub 2021 Jan 7.

Servicio de Medicina Interna, Hospital Universitario Río Hortega, Valladolid, Spain. Electronic address:

Background And Objectives: Osteoporosis is considered a generalised skeletal disorder in which there is impaired bone resistance, which predisposes the individual to a greater risk of fracture. The aim of this cross-sectional study was to collect and present data on the main clinical characteristics of patients who consult medical internists in Spain. Understanding these characteristics can help in implementing action plans to improve these patients' care more effectively and efficiently. Read More

View Article and Full-Text PDF
January 2021

Closed Transverse Pinning for Reduction and Fixation of Metatarsal Neck Fractures: Surgical Technique.

Indian J Orthop 2021 Jun 16;55(3):758-762. Epub 2020 Jun 16.

Dr Baba Saheb Ambedkar Medical College and Hospital, Rohini, India.

Most metatarsal neck fractures can be successfully treated non-operatively in a cast boot. Displaced metatarsal neck fractures tend to be less stable and have a propensity for the distal fragment to angulate, secondary to the strong flexor tendons, which often forces the distal fracture fragment in a plantar direction and leads to relative metatarsal shortening. Most literature is focussed on antegrade fixation of metatarsal neck fractures using pre-bent K wires or thin elastic nails. Read More

View Article and Full-Text PDF

Risk Factors for Refracture following Primary Osteoporotic Vertebral Compression Fractures.

Pain Physician 2021 May;24(3):E335-E340

Department of Orthopedics, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.

Background: In the aging population, osteoporosis and related complications have become a global public health problem. Osteoporotic vertebral compression fractures are among the most common type of osteoporotic fractures and patients are at risk of secondary vertebral compression fracture.

Objectives: To identify risk factors for secondary vertebral compression fracture following primary osteoporotic vertebral compression fractures. Read More

View Article and Full-Text PDF

Denosumab for the treatment of primary pediatric osteoporosis.

Osteoporos Int 2021 May 13. Epub 2021 May 13.

Center for Bone Quality, Department of Internal Medicine, Section Endocrinology, Leiden University Medical Center, Leiden, The Netherlands.

Primary osteoporosis is rare in children and adolescents and its optimal pharmacological management is uncertain. Bisphosphonates are commonly used while denosumab has only been administered to a few children with osteogenesis imperfecta. We studied a treatment-naïve 13. Read More

View Article and Full-Text PDF

Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.

Bone Rep 2021 Jun 16;14:101068. Epub 2021 Apr 16.

Department of Orthopaedic Surgery, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan.

Real-world data on the new anti-sclerostin antibody drug, romosozumab, remain scarce. There is a strong need to accumulate and analyze data on romosozumab treatment for such conditions as osteoporosis. The purpose of this study was to investigate the therapeutic and adverse effects of romosozumab for osteoporosis treatment in clinical practice. Read More

View Article and Full-Text PDF

Suppression of cancer-associated bone loss through dynamic mechanical loading.

Bone 2021 May 8;150:115998. Epub 2021 May 8.

Stony Brook University, Department of Biomedical Engineering, Stony Brook, NY, USA.

Patients afflicted with or being treated for cancer constitute a distinct and alarming subpopulation who exhibit elevated fracture risk and heightened susceptibility to developing secondary osteoporosis. Cancer cells uncouple the regulatory processes central for the adequate regulation of musculoskeletal tissue. Systemically taxing treatments to target tumors or disrupt the molecular elements driving tumor growth place considerable strain on recovery efforts. Read More

View Article and Full-Text PDF